Categories
Pharmaceutical

Pediatric HIV Infection Treatment Market Overview Will Help Impressive Advancement Prospects By 2026

Fact.MR has prepared and presented a research report on the Global Pediatric HIV Infection Treatment Market and has made optimum utilization of various multi-disciplinary approaches to arrive at the estimates and conclusions that have been shared in the report. The Global Pediatric HIV Infection Treatment Market has been prepared for a period of forecast that extends from 2021 to 2026. Offering an in-depth analysis of the major opportunities of growth and key prospects in the estimation year, the report has been drawn up a team of seasoned analysts who have meticulously assessed all the factors pertaining to the market. The report also explains vividly the prevailing dynamics of growth in the market over the assessment period, 2021 to 2026.

At the same time, the study prepares the stakeholders for dealing with the threats and challenges related to the global Pediatric HIV Infection Treatment market effectively and efficiently. The experience and knowledge of the researchers and analysts have been leveraged in authoring this report so as to offer a detailed report. Authors have meticulously considered the prevailing pandemic, SARS-CoV-2 induced Covid-19, and have taken the implications of the outbreak into consideration to arrive at the estimations and conclusions. Analysts at Fact.MR has made a careful analysis of the market in pre- and present Covid-19 times to derive estimations and projections for the Global Pediatric HIV Infection Treatment Market in the post-pandemic era.

Get Request for PDF Brochure of This Market Research Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=874

Multiple rounds of primary and exhaustive secondary research have been conducted and the data thus gathered have been utilized to analyze by the professionals at Fact.MR to come up with accurate estimations and projections for the Global Pediatric HIV Infection Treatment Market.

In an effort to provide the users of this report with a comprehensive view of the Global Pediatric HIV Infection Treatment Market, experts have included an elaborate discussion on the competitive scenario and product portfolio of each of the key vendors spread across various geographies.

The report study also makes inclusion of SWOT analysis and PESTEL analysis of the said industry. The study incorporates a market attractiveness analysis, in which all of the segments have been benchmarked based on their growth rate, market size, and general attractiveness in terms of incremental value growth and investment opportunity.

To understand of the competitive landscape in the Global Pediatric HIV Infection Treatment Market better, the report covers the profile of the following top players:

GlaxoSmithKline plc., F. Hoffmann-La Roche Ltd, ViiV Healthcare, Camber Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Apotex Inc., and others.

GLOBAL PEDIATRIC HIV INFECTION TREATMENT MARKET: SEGMENTATION

  • Segmentation by Type
    • Not symptomatic
    • Mildly symptomatic
    • Moderately symptomatic
    • Severely symptomatic
  • Segmentation by Treatment
    • Antiretroviral (ARV) drugs
      • Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
      • Protease Inhibitor (PI)
      • Integrase Strand Transfer Inhibitor (INSTI)
      • Others
    • Supportive care
  • Segmentation by Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Drugstore
    • e-commerce

The global Pediatric HIV Infection Treatment market report covers the following regions: 

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Get Request for Report Customization @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=874

The study makes an all-out effort to analyze the trends prevalent in the market and how each of these trends could present lucrative scope for investment from various end-use sectors and subsequently bolster revenue of the market over the forecast tenure.

The report gives an objective and pragmatic outlook on key trends pertaining to:

  • Consumer buying patterns and propensities
  • Changes in consumer sentiment due to the pandemic and other subsidiary factors
  • The net change in market demand over the past years
  • The leading industrial trends that have contributed to market maturity
  • Use of new technologies and development of fresh products/services by the vendors

Enquiry before Buying @ https://www.factmr.com/connectus/sample?flag=EB&rep_id=874

The report answers, in detail, the following key questions pertaining to market expansion:

  • Which regulatory compliances are essential for legally existing and entering into the market?
  • Which factors could be a threat, opportunity, or untapped territory for the market vendors?
  • Which regions are expected to offer fresh opportunities for establishing footholds in the market?
  • What are the odds and opportunities of remaining in the market despite the challenges and disruptions?

The report addresses the following doubts related to the Pediatric HIV Infection Treatment Market:

  1. Which company in the Pediatric HIV Infection Treatment market is leading in terms of innovation?
  2. The demand from which end-user is expected to drive the growth of the Pediatric HIV Infection Treatment market?
  3. What are the growth opportunities for market players in the developing regions?
  4. What are the various distribution channels adopted by market players in the Pediatric HIV Infection Treatment market?
  5. How are emerging market players establishing their presence in the current market landscape?

More Related Reports By Fact.MR On Healthcare Domain:

Intranasal migraine drugs Market: Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Oral Antivirals Market: Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Latest Now: NavigaWaldenstrom Macroglobulinemia Market Estimated To Experience A Hike In Growth Global Industry Size, Growth, Segments, Revenue, And Manufacturers

The Global NavigaWaldenstrom Macroglobulinemia Market study presents an all in all compilation of the historical, current and future outlook of the market as well as the factors responsible for such a growth. With SWOT analysis, the business study highlights the strengths, weaknesses, opportunities and threats of each NavigaWaldenstrom Macroglobulinemia market player in a comprehensive way. Further, the NavigaWaldenstrom Macroglobulinemia market report emphasizes the adoption pattern of the NavigaWaldenstrom Macroglobulinemia across various industries.

The detailed assessments focus on, inter alia, on the regulatory and macroeconomic frameworks, prevailing pricing structure, imminent investment pockets, and emerging application areas. Taking the analysis further, the study helps readers get a better understanding of the trends characteristics of the emerging markets, including government regulations crucial to growth of such markets. Shares of major regional markets are also presented in the analysis.

Get Request for PDF Brochure of This Market Research Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2580

The study provides detailed profile of key players and their offering in the NavigaWaldenstrom Macroglobulinemia market, which include

Baxter International Inc., Teva Pharmaceutical Industries Ltd., Bayer AG, Janssen Pharmaceutica NV (Johnson & Johnson), Merck & Co Inc., Hospira (Pfizer Inc.), Takeda Pharmaceutical Company Limited., Amgen Inc., Novartis AG and (Genentech) F. Hoffman-La Roche AG, among others.

The report offers insight into the competitive dynamic in the NavigaWaldenstrom Macroglobulinemia market which has shaped the major strategies of each player. It also covers recent moves such as partnerships and collaborations, mergers and acquisitions, diversification and research investments, of each prominent player. The key factors that shape the entry barrier and intensity of competition in the NavigaWaldenstrom Macroglobulinemia market are presented in the analysis. Further, the study provides PESTLE analyses of numerous players and an evaluation of how the competitive landscape will evolve over the forecast period.

Global NavigaWaldenstrom Macroglobulinemia Market Research Report Segmentation:

The global Waldenstrom macroglobulinemia market can be segmented on the basis of treatment, distribution channel and geography.

Based on treatment, the global Waldenstrom macroglobulinemia market is segmented as:

  • Chemotherapy
    • Alkylating agents
      • Cyclophosphamide (Cytoxan)
      • Bendamustine (Treanda)
    • Purine analogs
      • Fludarabine (Fludara)
      • Cladribine (2-CdA, Leustatin)
    • Corticosteroids
      • Prednisone
      • Dexamethasone (Decadron)
    • Others
      • Vincristine (Oncovin)
      • Doxorubicin (Adriamycin)
    • Targeted Therapy
      • Proteasome Inhibitors (bortezomib, carfilzomib)
      • mTOR inhibitors (Everolimus)
      • Bruton tyrosine kinase (BTK) inhibitors (ibrutinib)
    • Biological/immunotherapy
      • Monoclonal antibodies (rituximab, ofatumumab, alemtuzumab)
      • Immunomodulating Agents (Pomalidomide, Thalidomide)
      • Cytokines (Interfero)
    • Plasmapheresis
    • Stem Cell Transplantation

Based on distribution channel, the global Waldenstrom macroglobulinemia market is segmented as:

  • Hospitals
  • Specialty Cancer Clinics

To have better understanding of regional dynamics, Global NavigaWaldenstrom Macroglobulinemia Market covers the following geographies: 

  1. North America (U.S., Canada)
  2. Latin America (Mexico, Brazil)
  3. Western Europe (Germany, Italy, France, U.K, Spain)
  4. Eastern Europe (Poland, Russia)
  5. Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  6. Japan
  7. The Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Get Request for Report Customization @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=2580

Some important questions that the NavigaWaldenstrom Macroglobulinemia market report tries to answer exhaustively are:

  • Key strategic moves by various players in the NavigaWaldenstrom Macroglobulinemia market in recent years with respect to product launches, deals and tie-ups, and mergers and acquisitions, and divestment of shares.
  • Which strategies will enable top players in the NavigaWaldenstrom Macroglobulinemia market to expand their geographic footprints?
  • Which new business models are expected to change the course of growth of key regional markets in near future?
  • Which technologies will witness most attractive research investments and what will be the key sources of funding for startups and new entrants?
  • Which products segments have in recent years have seen new, lucrative application areas?

The global NavigaWaldenstrom Macroglobulinemia market report answers numerous pertinent questions, some of which are:

  • What are some of the latent areas of investments in the NavigaWaldenstrom Macroglobulinemia market?
  • Which region is expected to emerge as showing the most attractive growth rate during the forecast period and which factors will be crucial to its growth?
  • What trends are likely to change the status quo of the positions held by leading players of the NavigaWaldenstrom Macroglobulinemia market in the not-so-distant future?
  • Which product/service/technology segments holds game-changing potential to dramatically shape the competitive dynamic in the NavigaWaldenstrom Macroglobulinemia market?
  • What are the strategies adopted by top players to retain their stronghold in the NavigaWaldenstrom Macroglobulinemia market?
  • Which strategic moves will new entrants adopt to gain a strong foothold in the NavigaWaldenstrom Macroglobulinemia market?

Enquiry before Buying @ https://www.factmr.com/connectus/sample?flag=EB&rep_id=2580

After reading the NavigaWaldenstrom Macroglobulinemia market report, readers get insight into:

  • Major drivers and restraining factors, opportunities and challenges, and the competitive landscape
  • New, promising avenues in key regions
  • New revenue streams for all players in emerging markets
  • Focus and changing role of various regulatory agencies in bolstering new opportunities in various regions
  • Demand and uptake patterns in key industries of the NavigaWaldenstrom Macroglobulinemia market
  • New research and development projects in new technologies in key regional markets
  • Changing revenue share and size of key product segments during the forecast period
  • Technologies and business models with disruptive potential

How can Fact.MR Make Difference?

  1. In-depth understanding of key industry trends shaping the present growth dynamics
  2. Offers value chain analysis and price trend analysis of various offering of competitors
  3. Offers data-drive decision to help companies decide strategies that need recalibration
  4. Offers insights into areas in research and development that should attract
  5. Identifies data outliers before your competitors

More Related Reports By Fact.MR On Healthcare Domain:

Tissue Processor Equipment Market – Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

Epigenetics Market – Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Osteopenia Treatment Market: Industry Insights, Trends and Forecast up to 2026

This study on the Osteopenia Treatment Market gives the stakeholder and CXOs unmatched insights that can help to take their business to great heights. The study is a diverse mix of data from local expertise, a deep focus on niche and emerging technologies, and global coverage on all aspects related to the growth of the Osteopenia Treatment market. All these factors will help the stakeholders and CXOs climb the ladder of success.

The researchers at Fact.MR follow the F.I.X (Focus on trends. Industrial Dimensions. Extraordinary Geographical Insights.) Mechanism. This mechanism focuses on fixing the problems in the way of the stakeholders and CXOs in the Osteopenia Treatment market.

The study also focuses on the changing dynamics of the Osteopenia Treatment market during the forecast period of 2021-2026. The researchers make a deep dive into the pain points and threats revolving around the Osteopenia Treatment market. This makes the stakeholder aware of the situation and allows him/her to strategize and take steps accordingly.

Get Request for PDF Brochure of Osteopenia Treatment Market Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2579

Focus on Trends

The researchers at Fact.MR carry scrutinized research on all the trends surrounding the Osteopenia Treatment market. These findings are included and constantly upgraded in the report to let the stakeholders understand them and take decisions accordingly. The researchers also try to analyze the emerging trends that have the potential to invite shining growth across the Osteopenia Treatment market during the forecast period.

Industrial Dimensions

The study includes the list of well-established players in the Osteopenia Treatment market. The researchers keep an eye on the latest mergers, acquisitions, partnerships, joint ventures, and collaborations between the players of the Osteopenia Treatment market. The news about the latest expansions and investments across the Osteopenia Treatment market is also included in the study. Some of the well-known participants included in the Osteopenia Treatment market are:

Bayer, Primus Pharmaceuticals, Inc., Eurotec Medical Systems s.r.l., GE Healthcare, Hologic Inc., Osteosys Corp., Swissray, DMS Imaging, Medonica Co. Ltd., Demetech AB and others.

GLOBAL OSTEOPENIA TREATMENT MARKET SEGMENTATIONS

The global osteopenia treatment market can be segmented on the basis of test, method, end user and geography.

Based on test, the global Osteopenia Treatment market is segmented as:

  • Quantitative Computed Tomography (QCT)
  • Peripheral Quantitative Computed Tomography (pQCT)
  • Dual Energy X-ray Absorption (DEXA)
  • Peripheral Dual Energy X-ray Absorption (pDXA)
  • Others

Based on method, the global osteopenia treatment market is segmented as:

  • Invasive
  • Non-Invasive

Based on end user, the global Osteopenia Treatment market is segmented as:

  • Hospitals
  • Orthopedic Clinics
  • Others

Extraordinary Geographical Insights

The study includes the regions associated with the Osteopenia Treatment market and also reveals the region that will observe promising growth across the assessment period of 2021-2026. The researchers, with the help of local expertise, have performed a systematic analysis of each region. Every region has different demographics and the studies are carried in accordance with the changing demographics.

The regions included in the study on the Osteopenia Treatment market are as follows: 

  1. North America (U.S. and Canada)
  2. Latin America (Mexico, Brazil, Peru, Chile, and others)
  3. Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  4. Eastern Europe (Poland and Russia)
  5. Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  6. Middle East and Africa (GCC, Southern Africa, and North Africa)

Get Request For Report Customization @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=2579

COVID-19 Impact

The COVID-19 outbreak has created havoc across the world. Various businesses have suffered tremendous losses. The pandemic has changed the dynamics of every sector drastically. The Fact.MR researchers have performed a detailed study on the impact of the novel coronavirus outbreak on the Osteopenia Treatment market.

The researchers have also made a compared study of various factors according to the pre-corona era and post-corona era. This will give a clear picture of the effect of the COVID-19 outbreak on the Osteopenia Treatment market to the stakeholder.

Enquiry Before Buying @ https://www.factmr.com/connectus/sample?flag=EB&rep_id=2579

Some of the important questions covered in this study are as follows:

  • What are the prominent growth factors that will harness growth for the Osteopenia Treatment market during the forecast period?
  • Which end-use industry will garner considerable growth for the Osteopenia Treatment market?
  • Which region will emerge as a champion growth-contributor during the assessment period?
  • What are the obstacles surrounding the Osteopenia Treatment market? 

Through the latest research report on Osteopenia Treatment market, the readers get insights on:

  • Drivers, opportunities, restraints, and trends that show the impact on the development of the global Osteopenia Treatment market.
  • Reliable data on important regions and potential growth opportunities for vendors operating Osteopenia Treatment market in those regions.
  • Important insights on consumption, production, history, and forecast on potential avenues in the global Osteopenia Treatment market.

More Related Reports By Fact.MR On Healthcare Domain:

Endoscope Flushing Pumps Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Dual Therapy Stent Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Dual Therapy Stent Market Overview Will Help Impressive Advancement Prospects By 2031

This study on the Dual Therapy Stent Market gives the stakeholder and CXOs unmatched insights that can help to take their business to great heights. The study is a diverse mix of data from local expertise, a deep focus on niche and emerging technologies, and global coverage on all aspects related to the growth of the Dual Therapy Stent market. All these factors will help the stakeholders and CXOs climb the ladder of success.

The researchers at Fact.MR follow the F.I.X (Focus on trends. Industrial Dimensions. Extraordinary Geographical Insights.) Mechanism. This mechanism focuses on fixing the problems in the way of the stakeholders and CXOs in the Dual Therapy Stent market.

The study also focuses on the changing dynamics of the Dual Therapy Stent market during the forecast period of 2021-2031. The researchers make a deep dive into the pain points and threats revolving around the Dual Therapy Stent market. This makes the stakeholder aware of the situation and allows him/her to strategize and take steps accordingly.

Get Request for PDF Brochure of Dual Therapy Stent Market Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=572

Focus on Trends

The researchers at Fact.MR carry scrutinized research on all the trends surrounding the Dual Therapy Stent market. These findings are included and constantly upgraded in the report to let the stakeholders understand them and take decisions accordingly. The researchers also try to analyze the emerging trends that have the potential to invite shining growth across the Dual Therapy Stent market during the forecast period.

Industrial Dimensions

The study includes the list of well-established players in the Dual Therapy Stent market. The researchers keep an eye on the latest mergers, acquisitions, partnerships, joint ventures, and collaborations between the players of the Dual Therapy Stent market. The news about the latest expansions and investments across the Dual Therapy Stent market is also included in the study. Some of the well-known participants included in the Dual Therapy Stent market are:

Abbott, Boston Scientific, Cardinal Health, Cook Medical, Alvimedica, B.Braun, OrbusNeich, ORBUSNEICH Medtronic PLC, Ostial Corporation.

GLOBAL DUAL THERAPY STENT MARKET SEGMENTATIONS

By use

  • Single-use
  • Multi-use

By Industry

  • Hospitals
  • Clinics

Extraordinary Geographical Insights

The study includes the regions associated with the Dual Therapy Stent market and also reveals the region that will observe promising growth across the assessment period of 2021-2031. The researchers, with the help of local expertise, have performed a systematic analysis of each region. Every region has different demographics and the studies are carried in accordance with the changing demographics.

The regions included in the study on the Dual Therapy Stent market are as follows: 

  1. North America (U.S. and Canada)
  2. Latin America (Mexico, Brazil, Peru, Chile, and others)
  3. Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  4. Eastern Europe (Poland and Russia)
  5. Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  6. Middle East and Africa (GCC, Southern Africa, and North Africa)

Get Request For Report Customization @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=572

COVID-19 Impact

The COVID-19 outbreak has created havoc across the world. Various businesses have suffered tremendous losses. The pandemic has changed the dynamics of every sector drastically. The Fact.MR researchers have performed a detailed study on the impact of the novel coronavirus outbreak on the Dual Therapy Stent market.

The researchers have also made a compared study of various factors according to the pre-corona era and post-corona era. This will give a clear picture of the effect of the COVID-19 outbreak on the Dual Therapy Stent market to the stakeholder.

Enquiry Before Buying @ https://www.factmr.com/connectus/sample?flag=EB&rep_id=572

Some of the important questions covered in this study are as follows:

  • What are the prominent growth factors that will harness growth for the Dual Therapy Stent market during the forecast period?
  • Which end-use industry will garner considerable growth for the Dual Therapy Stent market?
  • Which region will emerge as a champion growth-contributor during the assessment period?
  • What are the obstacles surrounding the Dual Therapy Stent market? 

Through the latest research report on Dual Therapy Stent market, the readers get insights on:

  • Drivers, opportunities, restraints, and trends that show the impact on the development of the global Dual Therapy Stent market.
  • Reliable data on important regions and potential growth opportunities for vendors operating Dual Therapy Stent market in those regions.
  • Important insights on consumption, production, history, and forecast on potential avenues in the global Dual Therapy Stent market.

More Related Reports By Fact.MR On Healthcare Domain:

Paper Based Diagnostic Test Kits Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

Graft Delivery Devices Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Neonatal Monitoring Equipment Market to Record a 5.7% CAGR Through 2028

The ever-evolving Coronavirus (COVID-19) has caused interruptions in supply chains of companies in the Neonatal Monitoring Equipment Market. Through careful analysis of the COVID-19, our analysts at Fact.MR offer you a bird’s eye view of the current on goings of top tier companies in the Neonatal Monitoring Equipment Market. Learn how leading companies are striking potential partnership agreements to generate sales in the Neonatal Monitoring Equipment Market.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=746

Increased interest of neonatal monitoring equipment manufacturers in providing technologically-integrated and high-end solutions mirrors the healthcare sector’s inclination toward value-based care. Innovative technology offerings of new neonatal monitoring equipment manufacturers coupled with their attractive pricing has compelled major companies in expanding their product portfolio for meeting the requirement of neonatal intensive care units (NICUs).

Recent Fact.MR report envisages the neonatal monitoring equipment market to record a steady 5.7% CAGR during the forecast period (2018-2028). Over 1,070,000 neonatal monitoring equipment are pegged to be sold worldwide by 2028-end.

neonatal monitoring equipment market

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=746

Prominent players operating in the market such as Medtronic Plc, Natus Medical, Inc., Koninklijke Philips NV, and others, are upgrading their portfolio to make it cost-effective, maintain hospital-to-home point-of-care (PoC) continuum, and incorporate value-added services.

Segment-wise analysis & insights on neonatal monitoring equipment market has been offered that enables readers to gain accurate and transparent insights. The report has branched the neonatal monitoring equipment market in terms of product type, modality, end-user, and region.

Based on product type, key segments include,

  • Ventilator
  • Pulse Oximeter
  • Capnography Meter
  • Cardiorespiratory Monitor
  • Bilirubinometer
  • EEG Monitor
  • Blood Pressure Monitor

Based on modality, key segments include,

  • Portable Devices
  • Transportable Devices
  • Standalone Devices

Based on end-user, key segments include,

  • Hospitals
  • Neonatal Clinics
  • Nursing Homes
  • Diagnostic Centers
  • Other End-Users

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/746

Hospitals Focusing on Family-Centered Neonatal Care Offerings

Hospitals across the globe are entering into partnership with leading neonatal monitoring equipment manufacturers, in bid to offer family-centered neonatal care of highest quality. Developing advanced NICUs at their core, hospitals are focusing on the provision of supportive, and safe environment for accommodating ongoing family contact, and reducing neonatal stress. These instances point at increased demand for various neonatal equipment, and monitoring equipment are no exception. With the forecast value share of nearly 40% by 2028-end, hospitals will continue to lead the neonatal monitoring equipment market.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/01/16/1696700/0/en/Actigraphy-Sensor-and-PSG-Device-Manufacturers-Bullish-on-Wireless-and-USB-Technology-Adoption-Fact-MR-Study.html

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Bartter Syndrome Treatment Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2192/bartter-syndrome-treatment-market

Antibacterial Washcloth Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2190/antibacterial-washcloth-market

Acromegaly Treatment Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2191/acromegaly-treatment-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Sales of NGS Data Analysis Solutions Worldwide to Reach US$ 280 Mn in Revenues by 2026-end

According to a recently composed report of Fact.MR, the global NGS data analysis market will reflect an impressive expansion over the period, 2017 to 2026. Sales of NGS data analysis solutions worldwide are forecast to reach nearly US$ 280 Mn in revenues by 2026-end.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=505

NGS Data Analysis Bridging Gap between Genomic Research & Traditional DNA Sequencing Procedures

NGS data analysis has witnessed high demand among researchers, as it enables them in examining biological systems in detail, owing to its exceptional throughput scalability and speed in providing results. There has been a requirement for a greater level of understanding on the back of complexities involved in the genomic research than that offered by traditional DNA sequencing procedures.

NGS data analysis has bridged the gap between these levels of understanding requirements, emerging as an everyday research tool for researchers in the healthcare and medical sector. Constant developments in cloud computing & data integration solutions have enabled addressing bottlenecks of data handling effectively. Advent of NGS solutions in accordance with growing requirement of clinical diagnosis in personalizing treatment of several diseases and in genomic research, has entailed demand for precise & fast algorithm and sequencing interpretation tools for faster analysis of data. This has further resulted into demand for efficient and advanced solutions for the elaborate bioinformatics pipeline.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=505

However, infrastructural investments involved in the development of software and algorithms is likely to keep the market expansion in check. Solutions of NGS data analysis are time consuming, which in turn might confine its adoption to a certain extent. Commercial service providers however have lucrative opportunities in designing and developing novel solutions that offer faster turnaround times.

global ngs data analysis market

5 Key Future Projections of NGS Data Analysis Market for Forecast Period 2017-2026

  • On the basis of technique, sequencing by synthesis (SBS) has been estimated to remain dominant in the global NGS data analysis market, in terms of revenues. Ion semiconductor sequencing will also endure as a lucrative technique for NGS data sequencing worldwide. Revenues from real-time (SMRT) technology will continue to be sluggish in the market.
  • Academic research institutes will remain the most remunerative end-users of NGS data analysis. Sales of NGS data analysis solutions in academic research institutes are projected to record the fastest expansion through 2026.
  • Hospitals are also expected to prevail as lucrative end-users of NGS data analysis, with revenues poised to exceed US$ 60 Mn by 2026-end.
  • Based on service type, exome sequencing and RNA sequencing will continue to spearhead the global NGS data analysis market, in terms of revenues as well as sales expansion.
  • North America is expected to dominate the global NGS data analysis market, with revenues estimated to close in nearly US$ 115 Mn by 2026-end. Projected to exhibit the fastest expansion through 2026, North America will account for over one-third market revenue share through the forecast period.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/505

Market Taxonomy

Region

Service Type

End User

Technique

North America

Whole-Genome Sequencing

Hospitals

Sequencing by Synthesis (SBS) Technology

Latin America

Exome Sequencing

Academic Research Institutes

Real-Time (SMRT) Technology

Europe

Targeted Resequencing

Biotechnology/Pharmaceutical Companies

Ion semiconductor sequencing Technology

Japan

De Novo Sequencing

Contract Research Organization

Others

APEJ

RNA Sequencing

Other End Users

MEA

ChIP Sequencing

Methyl Sequencing

Other Services

Leading companies providing NGS data analysis solutions are undertaking strategic collaborations and partnerships for enhancing their existing product portfolios and maintaining a firm foothold in the global NGS data analysis market. These collaborations and partnerships are primarily aimed at the development of feasible infrastructure solutions, which enable researchers to perform a population-scale genomic analysis. Fact.MR’s report has listed key companies underpinning expansion of the global market for NGS data analysis, which include Advaita, Bina Technologies (Roche), Congenica, DNASTAR, Eagle Genomics, Flatiron, GENEWIZ, Qiagen, and Thermo Fisher Scientific, Inc.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/04/01/2010081/0/en/Cancer-Biomarker-Sales-to-Reach-US-27-Bn-by-2025-Government-Funding-Pivotal-in-Accelerating-Market-Growth-Says-a-New-Fact-MR-Report.html

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Medical Grade Silicone Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030: https://www.factmr.com/report/5439/medical-grade-silicone-market

Diabetes Diagnostics Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030: https://www.factmr.com/report/5446/diabetes-diagnostics-market

Dermatology Diagnostic Devices Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030: https://www.factmr.com/report/5453/dermatology-diagnostic-devices-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Revenues from Worldwide Sales of Emergency Medical Service Products to Reach US$ 34,000 Mn by 2026-end

According to Fact.MR, global emergency medical service products market is projected to register a CAGR of over 7% in terms of value over the forecast period, 2017 to 2026. Volume sales of emergency medical service products is estimated to reach roughly 99,000 units by 2026-end.

Uncertainty in Health Insurance can Impact EMS Organizations

Demand for emergency medical services (EMS) of operational as well as patient care data are likely to witness acceleration, with organizations tapping into this data for efficient operations. These organizations will also be able to demonstrate the value brought by them to the healthcare system and their communities.

For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=405

Leveraging this data, organizations are likely to discover greater value in the integrated data, which incorporates information received from multiple sources including data associated with outcomes and patient demographic from hospitals. Such data can further help increase the performance of devices & equipment such as emergency medical service (EMS) products used in hospitals and other healthcare settings. In addition, uncertainty in health insurance such as changes in Medicaid coverage, potential surges in uninsured patients, and higher deductibles are likely to have a major impact on EMS organizations, which are responsible for billing the patients’ insurance for services, particularly in terms of the way they are reimbursed, paid and the services they are paid.

global ems products market

Although value-based purchasing is increasingly being implemented across hospitals, its foray into EMS is yet to be realized. However, the scrutiny peripheral to quality of care brought to hospitals by value-based purchasing is indirectly impacting demand for emergency medical services and thereby its products. As hospitals seek ensuring maximum reimbursement for services provided, EMS is likely to be considered as an imperative partner for steering patients toward appropriate and the most effective care venue. With growing popularity of emergency medical services, demand for their products will witness a significant rise in the near future.

For critical insights on this market, request for methodology here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=405

Key Takeaways from Fact.MR’s Report on Emergency Medical Service Products Market

  • North America is expected to account for the largest revenue share of the market, followed by Europe and Asia-Pacific excluding Japan (APEJ). In terms of value, the emergency medical service products market in North America will record the highest CAGR through 2026, trailed by that in APEJ. In addition, the market in Europe will exhibit a steady expansion through the forecast period.
  • In terms of revenues, ECG monitor is anticipated to remain the dominant product in the market, trailed by EEG monitors. However, sales of EEG monitors will exhibit a comparatively faster expansion than those of ECG monitors through 2026, in terms of value. In addition, revenues from sales of pulse oximeters and intracranial pressure monitors are projected to register nearly similar CAGRs through 2026. Pulse oximeters and transcranial dopplers will continue to be the least lucrative products in the market.
  • Hospitals are slated to remain the largest as well as the fastest growing end-users of emergency medical service products, in terms of revenues. Over US$ 19,000 Mn worth of emergency medical products are expected to be sold in hospitals by 2026-end. In addition, revenues from sales in hospitals will remain significantly higher than those from clinics and ambulatory surgical centers combined.
  • Cardiac care will continue to be the most lucrative application of emergency medical service products, followed by trauma injuries. Sales of emergency medical service products for application in oncology will account for a major portion of the market’s revenue share by 2026-end.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/405

Market Taxonomy

End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Other End Users
Application
  • Cardiac Care
  • Trauma Injuries
  • Respiratory Care
  • Oncology
  • Other Applications

Key market players profiled by the report include Sourcemark LLC, QRS Diagnostic LLC, Norav Medical Ltd., Halyard Health, Inc., Dynarex Corporation, Cadwell Laboratories, Inc., Edan Instruments, Inc., Natus Medical, Inc., Smiths Medical (Subsidiary of Smiths Group PLC), Philips Healthcare, and GE Healthcare.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/07/26/1892334/0/en/Optometry-Equipment-Sales-Surge-in-Line-with-Industry-s-Focus-on-Easy-Access-and-Competitive-Price-Point-Says-Fact-MR.html

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Surgical Hand-Access Port Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2270/surgical-handaccess-port-market

Atrial Fibrillation (AF) Ablation Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2269/atrial-fibrillation-ablation-market

Carbapenem-resistant Enterobacteriaceae Testing Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2268/carbapenem-resistant-enterobacteriaceae-testing-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Global Amniocentesis Needle Market to Represent a Value of US$ 180 Mn by the End of 2026

As the need for removing excess of amniotic fluid arises, demand for amniocentesis needles in the healthcare industry is projected to remain high. In addition, prevalence of various diseases such as diabetes among the pregnant women is projected to impact the global market growth of amniocentesis needle positively. Fact.MR states that the global market of amniocentesis needle is projected to reflect a CAGR of 2.4% over the forecast period.

Factors Fuelling Growth of the Global Market

Growth of the global amniocentesis needle market is mainly bound to various macro-economic and micro-economic growth. Excess of amniotic fluid among the pregnant women can hinder the development of the babies. Increasing instance of increasing amniotic fluid among the pregnant women is mainly attributed to growing prevalence of various diseases.

For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=362

Prevalence of various diseases and disorders among the pregnant women leads to growing number of complicated cases, which can impact health of the babies in significantly. As a practice of breathing, the babies consume amniotic fluid during the developmental phase. However, excessive consumption of the amniotic fluid by the babies can impact the development of their brain and adversely impact their health. Growing need to maintain a balance and ensure adequate consumption of the amniotic fluid by the babies during the development phase has led the doctors and healthcare professionals to look for enhanced solutions. As the requirement to remove excessive amount of amniotic fluid arises, demand for the amniocentesis needles is projected to increase among the healthcare professionals significantly.

In addition, growing need to ensure good health and development of the babies during the development phase has led the healthcare professionals to conduct various procedures to check the level of amniotic fluid surrounding the baby. In order to check the level of amniotic fluid among the pregnant women has led to an upsurge in demand for amniocentesis needles in the healthcare industry significantly. Moreover, growing prevalence of various diseases such as diabetes among the pregnant women further leads to excessive buildup of amniotic fluid surrounding the baby. A recent report by CDC states that 2% to 10% of the pregnant women in the U.S. are increasingly effected by the gestational diabetes each year. Growing need to check and ensure the level of amniotic fluid among the pregnant women is projected to impact the global market growth of amniocentesis needles during the forecast period positively.

For critical insights on this market, request for methodology here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=362

Sales to Remain High in the Hospitals

As the requirement to remove the excess of amniotic fluid continues to increase, preference to use amniocentesis needles of 100-150 mm length is projected to remain high. In terms of revenues, the 100-150 mm size segment is projected to represent the highest growth, recording for more than US$ 30 Mn by 2026-end. On the other hand, the larger than 150 mm size segment is projected to reflect a significant CAGR during the forecast period.

On the basis of end users, the other end users segment is projected to reflect the fastest growth in the global market of amniocentesis needle throughout the forecast period. In contrary, the hospitals end users segment is projected to represent a robust revenue growth, accounting for more than US$ 26 Mn by 2017-end.

Based on procedure, the cordocentesis procedure segment is projected to reflect a healthy CAGR during the forecast period. However, the amniocentesis procedure segment is projected to witness a significant revenue growth, accounting for more than US$ 20 Mn by 2026-end.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/362

Market Players

Major players in the global market of amniocentesis needle are Cook Medical Inc., Medtronic Plc, Dickinson and Company, Becton, Integra Lifesciences Holdings Corporation, CooperSurgical Inc., Cardinal Health, Smiths Group Plc, LabIVF and Tsunami Medical Rocket Medical Plc.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/04/01/2010081/0/en/Cancer-Biomarker-Sales-to-Reach-US-27-Bn-by-2025-Government-Funding-Pivotal-in-Accelerating-Market-Growth-Says-a-New-Fact-MR-Report.html

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Surgical Hand-Access Port Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2270/surgical-handaccess-port-market

Atrial Fibrillation (AF) Ablation Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2269/atrial-fibrillation-ablation-market

Carbapenem-resistant Enterobacteriaceae Testing Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2268/carbapenem-resistant-enterobacteriaceae-testing-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Epistaxis Market to Represent a Value of US$ 13 Mn by the End of 2026

The market report envelopes an all-in information of the global Epistaxis market and the nature of the market growth over the foreseeable period. The report provides a comprehensive elaboration of the positives and negatives of the global Epistaxis market with DROT and Porter’s Five Forces analysis. With SWOT analysis, the report offers detailed insights about different players operating within the Epistaxis market. In addition, the analysts of the report have served the qualitative and quantitative scrutinizing of different micro- and macro-economic factors influencing the global Epistaxis market.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=344

In several emergency cases, oral doctors and maxillofacial surgeons are being called on in the hospitals to check the common case of nose-bleeding. This condition, medically known as epistaxis, has been one of the common pains for people through the age. Increasing exposure to physical traumas and harsh environment continue to factor the incidence of epistaxis across the globe. From physical assault to entry of foreign particles, epistaxis can be caused from a range of factors, increasing the need for appropriate and easily available medicine. Manufacturers of drugs are actively developing improved drugs on epistaxis to help people control persistent bleeding from the nose. A recently-published report by Fact.MR projects that in 2017, nearly US$ 150 Mn worth of epistaxis medicine and drugs will be sold across the globe.

The study further expects that by the end of 2026, the global epistaxis market will be worth over US$ 230 Mn value, expanding at an estimated 5.2% CAGR during the forecast period, 2017-2026. Key factors driving the sales of epistaxis have been addressed and analyzed in the report.

Research shows that common etiologies for epistaxis include blood dyscrasias, consumption of bioreactive medications, arteriovenous malformations, traumatic intubation, orthognathic surgeries, and oncological surgeries. Prevalence of such factors has necessitated the need for first-line medical assistance and management, which is greatly important for minimizing patient morbidity, and in worst cases, mortality. The report has considered several scenarios that project a robust growth in demand for epistaxis medicine in the foreseeable future.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=344

epistaxis market

Key Insights from the Report

The study has analyzed the global epistaxis market on the basis of indication, distribution channel, and product types. Key research findings on the segmental analysis of the global epistaxis market include:

  • In 2017, more than forty percent of revenues procured in the global epistaxis market will be accounted by the sales of cauterizing agents
  • Through 2026, global sales of cauterizing agents for epistaxis treatment are estimated to bring in nearly US$ 90 Mn
  • Hospitals will represent the largest distribution channel for epistaxis drugs, accounting for more than one-third share of global revenues during the forecast period
  • A majority of products sold in the global epistaxis market will be used in treatment of anterior epistaxis, revenues from which are estimated to be worth over US$ 200 Mn by 2026-end

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/344

Incidence of Epistaxis to Remain High in North America

Nosebleed is a common medical condition among the North American population. During their lifetime, more than three-fifth of the population in the US and Canada suffer from epistaxis. Depending on the causative factor, the degree of epistaxis varies from person to person, and robust healthcare infrastructure in the region guarantees the best medical assistance for North Americans suffering from epistaxis.

The report estimates that by the end of 2026, the epistaxis market in North America will be worth nearly US$ 90 Mn. The report further projects that the incidence of epistaxis will be considerably high in the Latin American region. Through 2026, Latin America will account for one-fourth revenue share in the global epistaxis market.

Key companies developing drugs on epistaxis have been profiled in the report. Ferring B.V., GlaxoSmithKline PLC, Smith & Nephew Plc., Medline Industries, Inc., Pfizer Inc., Ciron Drugs & Pharmaceuticals Pvt. Ltd., and Bristol-Myers Squibb Co. are expected to remain active in the expansion of the global epistaxis market through 2026.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/03/27/2007702/0/en/Tricuspid-Valve-Repair-Market-Poised-for-Astounding-Growth-Through-2029-Fact-MR-Projects-Annuloplasty-Rings-to-Remain-Top-Selling.html

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Surgical Hand-Access Port Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2270/surgical-handaccess-port-market

Atrial Fibrillation (AF) Ablation Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2269/atrial-fibrillation-ablation-market

Carbapenem-resistant Enterobacteriaceae Testing Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2268/carbapenem-resistant-enterobacteriaceae-testing-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Biomedical Refrigerators and Freezers Market to Garner a CAGR of 5.1% Through 2022

The market report envelopes an all-in information of the global Biomedical Refrigerators and Freezers market and the nature of the market growth over the foreseeable period. The report provides a comprehensive elaboration of the positives and negatives of the global Biomedical Refrigerators and Freezers market with DROT and Porter’s Five Forces analysis. With SWOT analysis, the report offers detailed insights about different players operating within the Biomedical Refrigerators and Freezers market. In addition, the analysts of the report have served the qualitative and quantitative scrutinizing of different micro- and macro-economic factors influencing the global Biomedical Refrigerators and Freezers market.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=343

Growing prevalence of various diseases is projected to boost demand for vaccines in the healthcare institutions globally. In addition, increasing advancements in biobanking techniques is projected to impact the global market growth positively. Fact.MR states that the global market of biomedical refrigerators and freezers is projected to reflect a CAGR of 5.7% over the forecast period, 2017-2022.

Factors Fuelling the Global Market Growth

Growth of the global biomedical refrigerators and freezers market is mainly bound to various macro-economic and micro-economic factors. Prevalence of various disorders is projected to boost demand for vaccines in various healthcare institutions. Treatment of various diseases will also continue to boost demand for blood and derivatives of blood. Biomedical freezers and refrigerators is projected to witness significant demand in the research laboratories, blood banks, educational institutions, hospitals and diagnostic centers. Surge in demand for storage of biomedical samples will continue to fuel adoption of biomedical refrigerator and freezers globally.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=343

Vaccination management is becoming a major concern in various healthcare and research institutions. Growing need for storing biomedical samples at exact and accurate temperature will further fuel adoption of biomedical freezers and refrigerators globally. Moreover, growth of the cell therapy has significantly revved up production of medicines, custom-made vaccine products and blood transfusion. Increasing demand for storage of the biomedical samples and products attributed to growing need for cell therapy is further projected to boost demand for biomedical freezers and refrigerators. These factors will continue to impact growth of the global market of biomedical refrigerators and freezers throughout the forecast period.

global biomedical refrigerators and freezers market

In addition, demand for biomedical freezers and refrigerators will further continue to increase due to growing investment in the research and development. Researchers are significantly focusing on development of various innovative treatment procedures and medical products for the treatment of various diseases. Development of innovative techniques and products has led to increasing demand for various biomedical samples globally. Educational institutions are also increasingly investing in research and development in collaboration with various healthcare institutions. Growing investment in research and development by various healthcare and educational institutions is projected to contribute towards the global market growth of biomedical refrigerators and freezers throughout the forecast period.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/343

Growing developments in the biobanking technology has transformed various aspects of science including biospecimen science and biorepository. With the growing advancements in biobanking, adoption of automated technology and robotic processing and handling process of the samples is projected to make the process of biobanking more effective. Moreover, development of various software applications that helps in storage management of blood and other biomedical samples is further projected to impact the global market growth of biomedical refrigerators and freezers positively.

Sales to Remain High Through Hospitals

As the requirement for storing blood and blood derivatives arise, demand for the plazma freezers is projected to increase globally. In terms of revenue, the plazma freezers product type segment is projected to represent the highest growth, representing more than US$ 400 Mn by 2022-end. In contrary, the cryogenic storage systems product type segment is projected to reflect a significant CAGR throughout the forecast period.

Market Players

Major players in the global market of biomedical refrigerators and freezers are Arctiko A/S, Aegis Scientific, Inc., Biomedical Solutions Inc., Binder GmbH, Coldway SA, Bionics Scientific Technologies Co., Ltd., Eppendorf AG, Desmon S.p.A, Gram Commercial SAS, Froilabo SAS, Liebherr International AG, LabRepco Inc., Philips Kirsch GmbH, Panasonic Healthcare Co., Ltd., Thermofisher Scientific Inc. and Terumo Corporation.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/03/17/2001977/0/en/Demand-for-Hospital-Supplies-to-Heighten-with-Severing-Concerns-over-Hospital-Infections-Global-Market-Value-to-Surpass-US-21-Bn-by-2029-Fact-MR.html

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Surgical Hand-Access Port Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2270/surgical-handaccess-port-market

Atrial Fibrillation (AF) Ablation Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2269/atrial-fibrillation-ablation-market

Carbapenem-resistant Enterobacteriaceae Testing Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028- https://www.factmr.com/report/2268/carbapenem-resistant-enterobacteriaceae-testing-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com